熱門資訊> 正文
Impact Biomedical宣布发行3F美国专利
2025-08-18 21:07
- Impact Biomedical (NYSE:IBO) announced on Monday that the US Patent and Trademark Office has issued a patent titled “Composition and Method of Controlling Infectious Diseases with Functional Fragrances,” developed within IBO’s 3F technology platform.
- The company said the patent relates to a unique composition and method for controlling infectious diseases. It also includes compositions and formulations of constituents found in plants and fragrances produced by plants, with potential application as an antibacterial or antiviral agent. The patent will expire on December 7, 2038.
- "Potential applications include killing microbes as a disinfectant and to be administered to a patient to treat an infectious disease condition. The composition has potential effectiveness against various pathogens including but not limited to E. coli, MRSA, influenza, rhinovirus, and M. tuberculosis," said the company.
- IBO +0.53% premarket to $0.5795.
- Source: Press Release
More on Impact BioMedical Inc.
- Financial information for Impact BioMedical Inc.
推薦文章
美股機會日報 | 估值8500億美元！傳OpenAI最新融資規模將破千億美元；黃仁勛稱將發佈幾款世界前所未見的新芯片
美股機會日報 | 凌晨3點！美聯儲將公佈1月貨幣政策會議紀要，納指期貨漲近0.5%；13F大曝光！巴菲特連續三季減持蘋果
美股機會日報 | 阿里發佈千問3.5！性能媲美Gemini 3；馬斯克稱Cybercab將於4月開始生產
港股周報 | 中國大模型「春節檔」打響！智譜周漲超138%；鉅虧超230億！美團周內重挫超10%
一周財經日曆 | 港美股迎「春節+總統日」雙假期！萬億零售巨頭沃爾瑪將發財報
從軟件到房地產，美國多板塊陷入AI恐慌拋售潮
Meta計劃為智能眼鏡添加人臉識別技術
危機四伏，市場卻似乎毫不在意
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
